EVEREST ORGANICS LTD. Share Price

EVEREST ORGANICS LTD. Share Price

BSE: 524790
|
Pharmaceuticals
|
S Cap
₹ 265.15
-₹9.85 (-3.58%)
1D
Last updated 11 Sep, 2026, 15:29 IST

EVEREST ORGANICS LTD. Share Price Today

As of 14 Sep 2026, EVEREST ORGANICS LTD. share price is ₹265.15. The stock opened at ₹265.05, compared to its previous close of ₹275.00. During today's trading session, EVEREST ORGANICS LTD. share price moved in the range of ₹260.00 to ₹266.00, with an average price of ₹263.00 for the day. Looking at its last 52-week, the stock has touched a low of ₹197.00 and a high of ₹536.40.

₹260.00
3.58% down today
₹266.00
1D LOW
1D HIGH

EVEREST ORGANICS LTD. Returns Calculator

Circuit
L
H
₹212.10
₹318.10
52-week
L
H
₹197.00
₹536.40

About EVEREST ORGANICS LTD.

EVEREST ORGANICS LTD. Share Price
ISIN
INE334C01029
Sector Market Cap
₹ 264.40 Cr

Everest Organics Limited is engaged in the business of manufacturing of active pharmaceutical ingredients (API) and intermediaries. It is involved in the manufacturing of bulk drugs. The Company’s API products include Omeprazole, Pantoprazole Sodium Sesquihydrate, Esomeprazole Magnesium Trihydrate, Esomeprazole Magnesium Dihydrate, Esomeprazole Sodium, Omeprazole Sodium, Omeprazole Magnesium, Fenofibrate, Tamsulosin Hcl, and Dexlansoprazole. Its products under development include Remdesivir, Molnupiravir, Carbidopa, Acotiamide HCL, and Apixaban. Its intermediates products include Ethyl 2-(4-Hydroxyphenyl)-4-Methyl-5-Thiazolecarboxylate, Ethyl 2-(3-Formyl-4-Hydroxyphenyl)-4-Methylthiazole-5- Carboxylate, Ethyl 2-(3-Formyl-4-Isobutoxyphenyl)-4-Methylthiazole-5-Carboxylate, Ethyl 2-(3-Cyano-4-Isobutoxyphenyl)-4-Methyl-5- Thiazolecarboxylate, 2-Chloromethyl-4-Methoxy-3-Methyl-Pyridine Hydrochloride, and 5-(1H-Pyroll-1-yl)-2-Mercaptobenzimidazole, among others.

EVEREST ORGANICS LTD. Financial Highlights

  • Revenue: EVEREST ORGANICS LTD. reported revenue of ₹197.41 crore in FY26 vs ₹160.17 crore in FY25. It showed an increase of 23.25% on a yearly basis.
  • Operating Profit: EVEREST ORGANICS LTD. reported an operating profit of ₹8.05 crore in FY26 vs ₹3.24 crore in FY25. It showed an increase of 348.46% on a year-on-year basis.
  • Net Profit: EVEREST ORGANICS LTD. reported a net profit of ₹5.55 crore in FY26 vs ₹1.29 crore in FY25. It showed an increase of 530.23% on a yearly basis.

EVEREST ORGANICS LTD. Quarterly Result Highlights

  • EVEREST ORGANICS LTD. reported revenue of ₹48.85 crore in Jun 2026, compared with ₹48.91 crore in Mar 2026, representing a decrease of 0.12% on a quarter-on-quarter (QoQ) basis.
  • EVEREST ORGANICS LTD. reported an operating profit of ₹1.53 crore in Jun 2026, compared with ₹2.17 crore in Mar 2026, representing a decrease of 29.49% on a quarter-on-quarter (QoQ) basis.
  • EVEREST ORGANICS LTD. reported a profit of ₹1.11 crore in Jun 2026, compared with ₹2.63 crore in Mar 2026, reflecting a decrease of 57.79% on a QoQ basis.
  • The earnings per share (EPS) of EVEREST ORGANICS LTD. stood at ₹2.97 during Jun 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Know more
Promoters
59.60%
FII
0.00%
Other DII
0.02%
Retail and other
40.37%
Mutual funds
0.00%
Foreign Institutional Investor (FII)
FII shareholding by period
Sep 20250.00%
Dec 20250.00%
Mar 20260.00%
Jun 20260.00%
Mkt Cap Cr
264.40
P/E
50.30
P/B
3.33
ROE
7.35%
D/E
0.66
ROCE
11.62%
Div. Yield
0.00%
EPS(TTM)
5.70
Turnover
0.80
EV/EBITDA
15.07
Net Margin
0.00%
Op. Margin
0.00%
ROA
2.19%
Quick Ratio
0.00
Curr. Ratio
1.53
Based on fundamentals, this stock's
Step 1 of 5
Performance
Very Poor
Everest Organics has not beaten FD return of 7%
Step 1 of 5
Valuation
Overvalued
Everest Organics appears overvalued compared to its peers
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROED/EROCEBook ValueDiv. YieldTurnoverEPS(TTM)
Sun Pharmaceutical Industries4,41,958.0036.485.2913.74%0.6117.33%93.240.87%0.4810.90
Divis Laboratories2,47,576.0084.6414.7715.32%0.0019.56%629.490.32%0.5598.19
Torrent Pharmaceuticals1,89,233.0087.7722.5025.49%1.6913.85%222.760.68%0.4958.70
Zydus Lifesciences1,11,671.0024.324.1218.59%0.3117.35%237.300.09%0.3335.38
Cipla1,10,273.0032.863.2011.27%0.0014.95%423.360.95%0.4543.52
Laurus Labs1,06,460.0097.6420.0916.77%0.4016.14%97.200.10%0.6713.72
Dr. Reddy's Laboratories96,906.4030.442.5511.07%0.1812.54%377.950.69%0.4138.68
Aurobindo Pharma96,401.7025.982.549.25%0.1911.76%394.820.24%0.3841.58
Lupin95,842.9017.274.2723.76%0.0424.88%659.000.86%0.57129.18
Mankind Pharma94,050.4045.495.7711.74%0.3413.13%396.980.04%0.4449.37

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

EVEREST ORGANICS LTD. Financials

Full statement

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Revenue₹159.48₹197.24₹183.05₹200.05
Other Income₹0.69₹0.89₹6.94₹2.21
Total Revenue₹160.17₹198.13₹189.99₹202.26
Total Expenses₹163.41₹197.52₹189.90₹200.52
Profit Before Tax-₹3.24₹0.61₹0.09₹1.74
Tax-₹1.95₹0.47₹0.27₹0.60
Profit After Tax-₹1.29₹0.14-₹0.18₹1.14
EPS - Basic-₹2.97₹0.17-₹0.23₹1.43
EPS - Diluted-₹2.97₹0.17-₹0.23₹1.43

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Profit before tax-₹3.24₹0.14-₹0.18₹1.14
Income before WC changes₹7.04₹10.79₹7.57₹7.87
Change in Assets₹6.23-₹17.50-₹14.43-₹29.64
Change in Liabilities-₹18.76₹23.13₹25.28₹35.51
Change in WC-₹12.53₹5.63₹10.85₹5.87
Cash flow from Operations-₹5.38₹16.42₹18.42₹13.74
Cash flow from Investing-₹5.17-₹13.32-₹15.60-₹16.82
Cash flow from Financing₹16.36-₹3.10-₹2.65₹2.07
Total Cash Flow₹5.82₹0.00₹0.18-₹1.01
Cash (Start of the year)₹0.27₹0.27₹0.65₹1.66
Cash (End of the year)₹6.09₹0.27₹0.83₹0.65

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Non-Current Assets₹76.58₹76.74₹69.37₹60.12
Current Assets₹147.90₹149.98₹132.48₹117.88
Total Assets₹224.48₹226.72₹201.85₹178.00
Current Liabilities₹139.92₹160.10₹137.58₹112.56
Net Current Asset₹7.98-₹10.12-₹5.10₹5.32
Non-Current Liabilities₹14.61₹20.78₹18.05₹18.64
Equity Capital₹69.95₹45.84₹46.21₹46.80
Total Equity & Liabilities₹224.48₹226.72₹201.85₹178.00
* All values are in INR Crore
Qty
Bid
0
0
0
0
0
0
0
0
0
0
Ask
Qty
0
0
0
0
0
0
0
0
0
0
Bid Total: 0
Ask Total: 0
Buy orders: 0%
Sell orders: 0%
Bearish
1
Neutral
4
Bullish
3
Slightly Bullish
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
38.99
Neutral
ATR (14)
12.25
Neutral
STOCH(9,6)
21.25
Neutral
STOCH RSI (14)
3.34
Bullish
ADX(9)
12.14
Bullish
UO(9)
48.24
Neutral
ROC(12)
-10.39
Bearish
WillR(14)
-88.67
Bullish
Period
Simple value
Exponential vaue
5D
270.75
270.57
10D
271.61
274.03
20D
284.06
280.44
50D
294.64
285.34
100D
277.43
293.8
Volume trend — traded volume by day
11 Sep0L
10 Sep0L
9 Sep0L
8 Sep0L
7 Sep0L
Average0L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks
EVEREST ORGANICS LTD. Share Price
EVEREST ORGANICS LTD.
Pharmaceuticals
Add Stock
Add Another

EVEREST ORGANICS LTD. Share Price FAQs

EVEREST ORGANICS LTD. share price data is sourced from NSE/BSE and may be delayed. It is displayed for informational purposes only and does not constitute investment advice or a recommendation to buy or sell.

Trusted by 2 Crore+ Indians for their wealth-building needs. SEBI Registered Broker. SEBI Reg No. INZ000315837